PubMed Health⌕ Search

PubMed · 9019721

[Ca2+]i elevation evoked by Ca2+ readdition to the medium after agonist-induced Ca2+ release can involve both IP3-, and ryanodine-sensitive Ca2+ release.

Abstract

Sustained Ca2+ elevation ("Ca2+ response"), caused by subsequent readdition of Ca2+ to the medium after application of adenosine 5'-triphosphate (ATP, 15 microM) in a Ca2+-free medium, was studied using single bovine aortic endothelial (BAE) cells. In cells in which the resting intracellular Ca2+ concentration ([Ca2+]i) was between about 50 and 110 nM, a massive Ca2+ response occurred and consisted of phasic and sustained components, whereas cells with a resting [Ca2+]i of over 110 nM displayed small plateau-like Ca2+ responses. An increase of internal store depletion resulted in loss of the phasic component. When the store was partly depleted, the dependence of the Ca2+ response amplitude on resting [Ca2+]i was biphasic over the range of 50 to 110 nM. The greatest degree of store depletion was associated with small monophasic Ca2+ responses, the amplitudes of which were almost constant and in the same range as resting [Ca2+]i. Ni2+, known to partly block Ca2+ entry, caused no change in the half-decay time of [Ca2+]i down to the level of the sustained phase [57 +/- 4 s in control and 54 +/- 3 s (n = 13) in the presence of 10 mM Ni2+] when added at the peak of the phasic component of the Ca2+ response. However, it lowered the sustained phase of the Ca2+ response by 42%. When applied at the start of the readdition of Ca2+, Ni2+ blocked the phasic component of the Ca2+ response, there being a threefold decrease in the initial rate of [Ca2+]i rise. In cells with a resting [Ca2+]i of 75-80 nM, pre-treatment with ryanodine (10 microM) did not affect the peak amplitude of the Ca2+ response, but it did increase the level of the sustained component. In some cells, ryanodine caused an oscillatory Ca2+ response. In conclusion, partial depletion of the inositol 1,4, 5-trisphosphate-(IP3-) sensitive store by a submaximal concentration of agonist (in Ca2+-free medium) was followed, on readdition of Ca2+, by Ca2+ entry, which appeared to trigger IP3-sensitive Ca2+ release (IICR) which, in turn, initiated Ca2+-sensitive Ca2+ release (CICR), thus resulting in a massive elevation of [Ca2+]i.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M G Mozhayeva. [Ca2+]i elevation evoked by Ca2+ readdition to the medium after agonist-induced Ca2+ release can involve both IP3-, and ryanodine-sensitive Ca2+ release.. https://doi.org/10.1007/s004240050265

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The human mitochondrial genome contains a second light strand promoter.

The human mitochondrial genome must be replicated and expressed in a timely manner to maintain energy metabolism and supply cells with adequate levels of adenosine triphosphate. Central to this process is the idea that replication primers and gene products both arise via transcription from a single light strand promoter (LSP) such that primer formation can influence gene expression, with no consensus as to how this is regulated. Here, we report the discovery of a second light strand promoter (LSP2) in humans, with features characteristic of a bona fide mitochondrial promoter. We propose that the position of LSP2 on the mitochondrial genome allows replication and gene expression to be orchestrated from two distinct sites, which expands our long-held understanding of mitochondrial gene expression in humans.

Adenosine Triphosphate↗

GCN2 kinase activation by ATP-competitive kinase inhibitors.

Small-molecule kinase inhibitors represent a major group of cancer therapeutics, but tumor responses are often incomplete. To identify pathways that modulate kinase inhibitor response, we conducted a genome-wide knockout (KO) screen in glioblastoma cells treated with the pan-ErbB inhibitor neratinib. Loss of general control nonderepressible 2 (GCN2) kinase rendered cells resistant to neratinib, whereas depletion of the GADD34 phosphatase increased neratinib sensitivity. Loss of GCN2 conferred neratinib resistance by preventing binding and activation of GCN2 by neratinib. Several other Food and Drug Administration (FDA)-approved inhibitors, such erlotinib and sunitinib, also bound and activated GCN2. Our results highlight the utility of genome-wide functional screens to uncover novel mechanisms of drug action and document the role of the integrated stress response (ISR) in modulating the response to inhibitors of oncogenic kinases.

Adenosine Triphosphate↗

Protein phosphorylation corrects the folding defect of the neuroblastoma (S120G) mutant of human nucleoside diphosphate kinase A/Nm23-H1.

Human nucleoside diphosphate (NDP) kinase A is a 'house-keeping' enzyme essential for the synthesis of nonadenine nucleoside (and deoxynucleoside) 5'-triphosphate. It is involved in complex cellular regulatory functions including the control of metastatic tumour dissemination. The mutation S120G has been identified in high-grade neuroblastomas. We have shown previously that this mutant has a folding defect: the urea-denatured protein could not refold in vitro. A molten globule folding intermediate accumulated, whereas the wild-type protein folded and associated into active hexamers. In the present study, we report that autophosphorylation of the protein corrected the folding defect. The phosphorylated S120G mutant NDP kinase, either autophosphorylated with ATP as donor, or chemically prosphorylated by phosphoramidate, refolded and associated quickly with high yield. Nucleotide binding had only a small effect. ADP and the non-hydrolysable ATP analogue 5'-adenyly-limido-diphosphate did not promote refolding. ATP-promoted refolding was strongly inhibited by ADP, indicating protein dephosphorylation. Our findings explain why the mutant enzyme is produced in mammalian cells and in Escherichia coli in a soluble form and is active, despite the folding defect of the S120G mutant observed in vitro. We generated an inactive mutant kinase by replacing the essential active-site histidine residue at position 118 with an asparagine residue, which abrogates the autophosphorylation. The double mutant H118N/S120G was expressed in inclusion bodies in E. coli. Its renaturation stops at a folding intermediate and cannot be reactivated by ATP in vitro. The transfection of cells with this double mutant might be a good model to study the cellular effects of folding intermediates.

Adenosine Triphosphate↗